Cargando…
On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2
The current epidemic of coronavirus disease-19 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) calls for the development of inhibitors of viral replication. Here, we performed a bioinformatic analysis of published and purported SARS-CoV-2 antivirals including imatin...
Autores principales: | Sauvat, Allan, Ciccosanti, Fabiola, Colavita, Francesca, Di Rienzo, Martina, Castilletti, Concetta, Capobianchi, Maria Rosaria, Kepp, Oliver, Zitvogel, Laurence, Fimia, Gian Maria, Piacentini, Mauro, Kroemer, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434849/ https://www.ncbi.nlm.nih.gov/pubmed/32814759 http://dx.doi.org/10.1038/s41419-020-02842-x |
Ejemplares similares
-
Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection
por: Ciccosanti, Fabiola, et al.
Publicado: (2021) -
A microRNA Arising from the Negative Strand of SARS-CoV-2 Genome Targets FOS to Reduce AP-1 Activity
por: Greco, Francesco, et al.
Publicado: (2023) -
Mitochondrial Interactome: A Focus on Antiviral Signaling Pathways
por: Refolo, Giulia, et al.
Publicado: (2020) -
AMBRA1 regulates mitophagy by interacting with ATAD3A and promoting PINK1 stability
por: Di Rienzo, Martina, et al.
Publicado: (2021) -
Type 2 transglutaminase in the nucleus: the new epigenetic face of a cytoplasmic enzyme
por: Rossin, Federica, et al.
Publicado: (2023)